Charles River Laboratories International, Inc.
CRL
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufactuā¦ read more
Healthcare
Diagnostics & Research
25 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$155.46
Price+1.83%
$2.80
1Y
Price
Market Cap
$7.653b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+20.0%
EBITDA Margin-27.8%
Net Profit Margin+5.9%
Free Cash Flow Margin+20.0%
EBITDA Margin-27.8%
Net Profit Margin+5.9%
Free Cash Flow MarginRevenue
$4.015b
-0.9%
1y CAGR+0.4%
3y CAGR+3.4%
5y CAGREarnings
-$144.338m
-1501.7%
1y CAGR-534.0%
3y CAGR-394.4%
5y CAGREPS
-$2.91
-1580.0%
1y CAGR-560.2%
3y CAGR-414.0%
5y CAGRBook Value
$3.211b
$7.135b
Assets$3.924b
Liabilities$3.066b
DebtDebt to Assets
43.0%
3.8x
Debt to EBITDAFree Cash Flow
$518.494m
+3.4%
1y CAGR+21.5%
3y CAGR+5.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company